Renal Cancers Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00301847Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the BrainTreatment
NCT00854620Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerTreatment
NCT00866320Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabTreatment